Lauren  Riker net worth and biography

Lauren Riker Biography and Net Worth

Lauren Riker is the SVP of Pacira BioSciences.

What is Lauren Riker's net worth?

The estimated net worth of Lauren Riker is at least $1.19 million as of February 2nd, 2026. Riker owns 52,313 shares of Pacira BioSciences stock worth more than $1,187,505 as of April 5th. This net worth approximation does not reflect any other investments that Riker may own. Learn More about Lauren Riker's net worth.

How do I contact Lauren Riker?

The corporate mailing address for Riker and other Pacira BioSciences executives is 5 SYLVAN WAY SUITE 300, PARSIPPANY NJ, 07054. Pacira BioSciences can also be reached via phone at (813) 553-6680 and via email at [email protected]. Learn More on Lauren Riker's contact information.

Has Lauren Riker been buying or selling shares of Pacira BioSciences?

Lauren Riker has not been actively trading shares of Pacira BioSciences within the last three months. Most recently, Lauren Riker sold 4,000 shares of the business's stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $20.81, for a transaction totalling $83,240.00. Following the completion of the sale, the senior vice president now directly owns 52,313 shares of the company's stock, valued at $1,088,633.53. Learn More on Lauren Riker's trading history.

Who are Pacira BioSciences' active insiders?

Pacira BioSciences' insider roster includes Marcelo Bigal (Director), Shawn Cross (CFO), Mark Froimson (Director), Mark Kronenfeld (Director), Frank Lee (Chief Executive Officer & Director), Donald Manning (Insider), Max Reinhardt (Insider), Charles Reinhart, III (CFO), Lauren Riker (VP), Lauren Riker (SVP), Jonathan Slonin (Chief Medical Officer), David Stack (CEO), Andreas Wicki (Director), Kristen Williams (Insider), Kristen Williams (Chief Administrative Officer & Secretary), and Roy Winston (Insider). Learn More on Pacira BioSciences' active insiders.

Are insiders buying or selling shares of Pacira BioSciences?

In the last twelve months, insiders at the sold shares 9 times. They sold a total of 52,087 shares worth more than $1,271,990.52. The most recent insider tranaction occured on March, 17th when insider Jonathan Slonin sold 3,261 shares worth more than $74,416.02. Insiders at Pacira BioSciences own 6.4% of the company. Learn More about insider trades at Pacira BioSciences.

Information on this page was last updated on 3/17/2026.

Lauren Riker Insider Trading History at Pacira BioSciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/2/2026Sell4,000$20.81$83,240.0052,313View SEC Filing Icon  
1/5/2026Sell1,416$24.24$34,323.8459,064View SEC Filing Icon  
6/4/2025Sell5,578$26.21$146,199.3859,564View SEC Filing Icon  
6/12/2024Sell3,970$28.72$114,018.4038,075View SEC Filing Icon  
See Full Table

Lauren Riker Buying and Selling Activity at Pacira BioSciences

This chart shows Lauren Riker's buying and selling at Pacira BioSciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pacira BioSciences Company Overview

Pacira BioSciences logo
Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.
Read More

Today's Range

Now: $22.70
Low: $22.19
High: $22.93

50 Day Range

MA: $22.15
Low: $19.85
High: $23.53

2 Week Range

Now: $22.70
Low: $18.80
High: $27.64

Volume

750,441 shs

Average Volume

749,355 shs

Market Capitalization

$919.12 million

P/E Ratio

151.33

Dividend Yield

N/A

Beta

0.19